Stabilisation of amorphous drugs under high humidity using pharmaceutical thin films

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 84, Issue 3, 2013, Pages 555-565

  Ng, Yuen Chuen ^a   Yang, Ziyi ^a   McAuley, William James ^b   Qi, Sheng ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

Amorphous; Crystallization; Pharmaceutical thin films; Phase separation; Polymer coating; Solid dispersions; Stabilisation

Indexed keywords

CARBAMAZEPINE; CELECOXIB; EUDRAGIT; FELODIPINE; FENOFIBRATE;

ARTICLE; ATOM TRANSFER RADICAL POLYMERIZATION; CRYSTALLIZATION; DRUG COATING; DRUG STABILITY; FILM; HUMIDITY; INFRARED SPECTROSCOPY; MICROSCOPY; SCANNING ELECTRON MICROSCOPY;

CARBAMAZEPINE; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DRUG DESIGN; FELODIPINE; FENOFIBRATE; HUMIDITY; MICROSCOPY, ELECTRON, SCANNING; POLYMERS; PYRAZOLES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SULFONAMIDES; SURFACE PROPERTIES; TEMPERATURE; TRANSITION TEMPERATURE; WETTABILITY;

EID: 84879126587     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2013.01.008     Document Type: Article

References (39)

1. A. Arya, A. Chandra, V. Sharma, and K. Pathak Fast dissolving oral films: an innovative drug delivery system and dosage form Int. J. ChemTech Res. 2 2010 576 583
2. A. Bose, P. Nelson, Endovascular Thin Film Devices and Methods for Treating and Preventing Stroke. United Sates Patent, 6, 605, 111, 2003.
3. H. Llanos, M. Roller, A. Scopelianos, Coating for Medical Devices, European Patent Specification, 1, 192, 957, 2007.
4. J.B. Ciolino, T.R. Hoare, N.G. Iwata, I. Behlau, C.H. Dohlman, R. Langer, and D.S. Kohane A drug-eluting contact lens Invest. Ophthalmol. Vis. Sci. 50 2009 3346 3352
5. L. Yu Amorphous pharmaceutical solids: preparation, characterization and stabilization Adv. Drug. Deliver. Rev. 48 2001 27 42
6. H. Konno, and L.S. Taylor Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine J. Pharm. Sci. 95 2006 2692 2705
7. Y. Sun, L. Zhu, T. Wu, T. Cai, E.M. Gunn, and L. Yu Stability of amorphous pharmaceutical solids: crystal growth mechanisms and effect of polymer additives AAPS J. 14 2012 380 388
8. T. Cai, L. Zhu, and L. Yu Crystallization of organic glasses: effects of polymer additives on bulk and surface crystal growth in amorphous nifedipine Pharm. Res. 28 2011 2458 2466
9. P.J. Marsac, A.C.F. Rumondor, D.E. Nivens, U.S. Kestur, L. Stanciu, and L.S. Taylor Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinylpyrrolidone) J. Pharm. Sci. 99 2010 169 185
10. P. Gupta, R. Thilagavathi, A.K. Chakraborti, and A.K. Bansal Role of molecular interaction in stability of celecoxib-PVP amorphous systems Mol. Pharm. 5 2005 384 391
11. A.C.F. Rumondor, P.J. Marsac, L.A. Stanford, and L.S. Taylor Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture Mol. Pharm. 6 2009 1492 1505
12. A.C.F. Rumondor, M.J. Jackson, and L.S. Taylor Effects of moisture on the growth rate of felodipine crystals in the presence and absence of polymers Cryst. Growth Des. 10 2009 747 753
13. A.C.F. Rumondor, and L.S. Taylor Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture Mol. Pharm. 7 2009 477 490
14. V. Andronis, M. Yoshioka, and G. Zografi Effects of sorbed water on the crystallization of indomethacin from the amorphous state J. Pharm. Sci. 86 1997 346 351
15. T. Konishi, and H. Tanaka Possible origin of enhanced crystal growth in a glass Phys. Rev. B 76 2007 220201
16. L. Zhu, L. Wong, and L. Yu Surface-enhanced crystallization of amorphous nifedipine Mol. Pharm. 5 2008 921 926
17. T. Wu, Y. Sun, and L. Yu Inhibiting surface crystallisation of amorphous indomethacin by nanocoating Langmuir 23 2007 5148 5153
18. Y. Sun, L. Zhu, K.L. Kearns, M.D. Ediger, and L. Yu Glasses crystallize rapidly at free surfaces by growing crystals upward PNAS 108 2011 5990 5995
19. M. Ponting, Y. Lin, K.J. Keum, A. Hiltner, and E. Baer Effect of substrate on the isothermal crystallization kinetics of confined poly(ε-caprolactone) nanolayers Macromolecules 43 2010 8619 8627
20. H. Zhang, T. Toru, Y. Takemura, M. Akiharu, Semiconductor Device Including a Plurality of Thin Film Transistors at Least Some of which have a Crystalline Silicon film Crystal-grown Substantially in Parallel to the Surface of a Substrate for the Transistor, United States Patent, 5, 604, 360, 1997.
21. Z. Dohnalek, G. Kimmel, R. Ciolli, K. Stevenson, R. Smith, and B. Kay The effect of the underlying substrate on the crystallization kinetics of dense amorphous solid water films J. Chem. Phys. 112 2000 13
22. J.A. Baird, B. Van Eerdenbrugh, and L.S. Taylor A classification system to assess the crystallization tendency of organic molecules from undercooled melts J. Pharm. Sci. 99 2010 3787 3806
23. B. Van Eerdenbrugh, J.A. Baird, and L.S. Taylor Crystallization tendency of active pharmaceutical ingredients following rapid solvent evaporation - classification and comparison with crystallization tendency from undercooled melts J. Pharm. Sci. 99 2010 3826 3838
24. L. Harding, W.P. King, X. Dai, D. Craig, and M. Reading Nanoscale characterisation and imaging of partially amorphous materials using local thermomechanical analysis and heated tip AFM Pharm. Res. 24 2007 2048 2054
25. J. Zhang, M. Bunker, X. Chen, A.P. Parker, N. Patel, and C.J. Roberts Nanoscale thermal analysis of pharmaceutical solid dispersions Int. J. Pharm. 380 2009 170 173
26. C. Rustichelli, G. Gamberini, V. Ferioli, M.C. Gamberini, R. Ficarra, and S. Tommasini Solid-state study of polymorphic drugs: carbamazepine J. Pharm. Biomed. Anal. 23 2000 41 55
27. L.E. McMahon, P. Timmins, A.C. Williams, and P. York Characterization of dihydrates prepared from carbamazepine polymorphs J. Pharm. Sci. 85 1996 1064 1069
28. A.L. Grzesiak, M.D. Lang, K. Kim, and A.J. Matzger Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I J. Pharm. Sci. 92 2003 2260 2271
29. Y. Li, J. Han, G.G.Z. Zhang, D.J.W. Grant, and R. Suryanarayanan In situ dehydration of carbamazepine dihydrate: a novel technique to prepare amorphous anhydratous carbamazepine Pharm. Dev. Technol. 5 2000 257 266
30. R. Surana, A. Pyne, and R. Suryanarayanan Solid-vapor interactions: influence of environmental conditions on the dehydration of carbamazepine dihydrate AAPS PharmSciTech 4 2003
31. B.C. Hancock, S.L. Shamblin, and G. Zografi Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures Pharm. Res. 12 1995 799 806
32. A.D. Gift, P.E. Luner, L. Luedeman, and L.S. Taylor Influence of polymeric excipients on crystal hydrate formation kinetics in aqueous slurries J. Pharm. Sci. 97 2008 5198 5211
33. F. Tian, N. Sandler, K.C. Gordon, C.M. McGoverin, A. Reay, C.J. Strachan, D.J. Saville, and T. Rades Visualizing the conversion of carbamazepine in aqueous suspension with and without the presence of excipients: a single crystal study using SEM and Raman microscopy Eur. J. Pharm. Biopharm. 64 2006 326 335
34. F. Tian, S. Baldursdottir, and J. Rantanen Effects of polymer additives on the crystallization of hydrates: a molecular-level modulation Mol. Pharm. 6 2008 202 210
35. S. Qi, J. Moffat, Z.Y. Yang, Early stage phase separation in pharmaceutical solid dispersion thin films under high humidity: improved spatial understanding using probe based thermal and spectroscopic nano-characterisation methods. Mol. Pharm., (2013), http://dx.doi.org/10.1021/mp 300557q.
36. R.F. Henry, G.Z. Zhang, Y. Gao, and I.S. Buckner Fenofibrate Acta Crystallogr. E 59 2003 699 700
37. P. Di Martino, G.F. Palmieri, and S. Martelli Evidence of a metastable form of fenofibrate Pharmazie 55 2000 625 626
38. g Pharm. Res. 23 2006 2350 2355
39. J.M. Sallese, A. Lls, D. Bouvet, and P. Fazan Modeling of the depletion of the amorphous-silicon surface during hemispherical grained silicon formation J. Appl. Phys. 88 2002